Jean Terrier

10PUBLICATIONS
12CO-AUTHORS
PharmacogenomicsToxicology (incl. clinical toxicology)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 04, 2025
Virtual twin approach using physiologically based pharmacokinetic modelling in hospitalized patients treated with apixaban or rivaroxaban.

Frédéric Gaspar, Jean Terrier, Celestin Jacot-Descombes

|Jan 11, 2025
Improving Understanding of Fexofenadine Pharmacokinetics to Assess Pgp Phenotypic Activity in Older Adult Patients Using Population Pharmacokinetic Modeling.

Frédéric Gaspar, Celestin Jacost-Descombes, Pauline Gosselin

|Nov 13, 2024
The Impact of Dexamethasone and Prednisone on Apixaban and Rivaroxaban Exposure in COVID-19 Patients: A Physiologically Based Pharmacokinetic Modeling Study.

Jean Terrier, Kenza Abouir, Frederic Gaspar

|Oct 05, 2023
Apixaban and rivaroxaban's physiologically-based pharmacokinetic model validation in hospitalized patients: A first step for larger use of a priori modeling approach at bed side.

Jean Terrier, Frédéric Gaspar, Pauline Gosselin

|Sep 19, 2023
Population pharmacokinetics of apixaban in a real-life hospitalized population from the OptimAT study.

Frédéric Gaspar, Jean Terrier, Samantha Favre

|May 20, 2022
Population Pharmacokinetic Models for Direct Oral Anticoagulants: A Systematic Review and Clinical Appraisal Using Exposure Simulation.

Jean Terrier, Frédéric Gaspar, Monia Guidi

Pageof 2

Frequent Collaborators

4 joint publications

Pierre Fontana

4 joint publications

Camille Lenoir

4 joint publications

Frédéric Gaspar

3 joint publications

Jean-Luc Reny